BioSpace News Archive

FDA

FDA Clears ImmunoCAP™ Blood Tests for Wheat and Sesame Allergy

Today, Thermo Fisher Scientific announces the clearance of ImmunoCAP Specific IgE (sIgE) Allergen Components for wheat and sesame* allergies by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use.

August 17, 2022
·
4 min read
Business

Sonoma Biotherapeutics Expands Board of Directors with Appointments of Katina Dorton, J.D., MBA, and John Davis, M.D., MPH

Sonoma Biotherapeutics, Inc. today announced the appointments of Katina Dorton, J.D., MBA, and John Davis, M.D., MPH, to its Board of Directors.

August 17, 2022
·
3 min read
BioMidwest

BioDerm, Inc. Readies for Direct-to-Consumer Growth with Executive Additions

BioDerm, Inc., a leading provider of disposable medical devices and wound care supplies, announced the addition of two executives to strengthen its leadership position in providing premium solutions for patients with chronic medical conditions.

August 17, 2022
·
2 min read
Biotech Beach

Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call

Ensysce Biosciences, Inc. today released an updated investor presentation to its investor relations website accessible via https://ir.ensysce.com/

August 17, 2022
·
2 min read
Business

James Mock Joins Moderna as Chief Financial Officer

Moderna, Inc. today announced that James Mock has been appointed as Moderna’s Chief Financial Officer, beginning September 6, 2022.

August 17, 2022
·
4 min read
Business

Kriya Appoints Pedro Huertas M.D., Ph.D., as Chief Medical Officer of its Rare Disease Division

Kriya Therapeutics, Inc announced today that it has appointed Pedro Huertas, M.D., Ph.D., as Chief Medical Officer of its Rare Disease Division.

August 17, 2022
·
2 min read
Business

Ainos Announces Master Services Agreement with Swiss Pharmaceutical, Ltd. for Drug Testing, Manufacturing, and Packaging for its VELDONA Product Candidates

Ainos, Inc. today announced it has signed a Master Service Agreement with Swiss Pharmaceutical Co., Ltd.

August 17, 2022
·
5 min read
Drug Development

Palisade Bio Announces First Patient Enrolled and Dosed in Pivotal Phase 3 Study Evaluating LB1148 for Postoperative Return of Bowel Function

Palisade Bio, Inc. today announced the first patient has been dosed in its Phase 3 study evaluating LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.

August 17, 2022
·
5 min read
BioMidwest

Blue Water Vaccines Announces Exploration of Its Virus-Like Particle (VLP) Platform for Use in Monkeypox Vaccine Candidate

Blue Water Vaccines Inc. today announced that the Company plans to explore the potential to develop a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle (VLP) platform.

August 17, 2022
·
4 min read
Biotech Beach

EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK

Edwards Lifesciences Corporation (NYSE: EW), today announced the company’s PASCAL Precision transcatheter valve repair system received CE Mark for the treatment of mitral and tricuspid regurgitation (MR and TR).

August 17, 2022
·
3 min read